Suppr超能文献

单侧非综合征性肾母细胞瘤成年幸存者的肾功能与身体组成:圣犹大终身队列研究报告

Kidney Function and Body Composition in Adult Survivors of Unilateral, Non-Syndromic Wilms Tumor: A Report From the St. Jude Lifetime Cohort Study.

作者信息

Green Daniel M, Li Kendrick, Kaste Sue C, Ness Kirsten K, Krasin Matthew J, Xie Lu, Wilson Carmen L, Srivastava DeoKumar, Jay Dennis W, Davidoff Andrew M, Zahr Rima S, Taneja Siddhant, Shelton Kyla C, Lanctot Jennifer Q, Dixon Stephanie B, Ehrhardt Matthew J, Mulrooney Daniel A, Armstrong Gregory T, Robison Leslie L, Hudson Melissa M

机构信息

Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

出版信息

Pediatr Blood Cancer. 2025 Mar;72(3):e31485. doi: 10.1002/pbc.31485. Epub 2024 Dec 17.

Abstract

BACKGROUND

The relationships among treatment exposures, body composition, and estimated glomerular filtration rate (eGFR) in adult survivors of Wilms tumor have not been well studied.

METHODS

We evaluated body composition with dual-energy x-ray absorptiometry (DXA) and eGFR with the updated Chronic Kidney Disease Epidemiology Collaboration equations (creatinine only-eGFR, cystatin C only-eGFR, creatinine and cystatin C-eGFR) without race in 134 adults previously treated for unilateral, non-syndromic Wilms tumor at St. Jude Children's Research Hospital between 1964 and 2004 with chemotherapy and with (hemiabdomen [HA] or whole abdomen [WA]) or without radiation therapy (RT). Z-scores for DXA variables were calculated using data from the National Health and Nutrition Examination Survey.

RESULTS

WART was associated with a lower relative total (p = 0.004) and trunk (p < 0.001) lean mass, eGFR (p = 0.008), eGFR (p < 0.001), and eGFR (p < 0.001), and higher values of cystatin C (p < 0.001). Linear regression demonstrated that relative total lean mass (p = 0.009) and relative trunk lean mass (p < 0.001) Z-scores, and eGFR (p = 0.013) were lower among those who received WART compared to No RT patients.

CONCLUSIONS

WART is associated with lower relative total and trunk lean mass Z-scores and eGFR, regardless of the equation used, and is lower in survivors treated with WART compared to unirradiated survivors of unilateral, non-syndromic WT. Assessments using other GFR measures may provide greater insight into the mechanism and magnitude of kidney function loss among WART-treated WT survivors.

摘要

背景

肾母细胞瘤成年幸存者的治疗暴露、身体成分与估计肾小球滤过率(eGFR)之间的关系尚未得到充分研究。

方法

我们采用双能X线吸收法(DXA)评估身体成分,并使用更新的慢性肾脏病流行病学协作方程(仅肌酐-eGFR、仅胱抑素C-eGFR、肌酐和胱抑素C-eGFR)在不考虑种族的情况下,对134名曾于1964年至2004年在圣裘德儿童研究医院接受单侧、非综合征性肾母细胞瘤治疗的成年人进行eGFR评估,这些患者接受了化疗,且接受(半腹部[HA]或全腹部[WA])或未接受放射治疗(RT)。使用来自美国国家健康和营养检查调查的数据计算DXA变量的Z分数。

结果

肾母细胞瘤放疗与较低的相对总(p = 0.004)和躯干(p < 0.001)瘦体重、eGFR(p = 0.008)、eGFR(p < 0.001)以及eGFR(p < 0.001)相关,且胱抑素C值较高(p < 0.001)。线性回归表明,与未接受放疗的患者相比,接受肾母细胞瘤放疗的患者相对总瘦体重(p = 0.009)和相对躯干瘦体重(p < 0.001)Z分数以及eGFR(p = 0.013)较低。

结论

无论使用何种方程,肾母细胞瘤放疗均与较低的相对总瘦体重和躯干瘦体重Z分数以及eGFR相关,且与单侧、非综合征性肾母细胞瘤未接受放疗的幸存者相比,接受肾母细胞瘤放疗的幸存者的上述指标更低。使用其他肾小球滤过率测量方法进行评估可能会更深入地了解接受肾母细胞瘤放疗的肾母细胞瘤幸存者肾功能丧失的机制和程度。

相似文献

3
4
Prospective analysis of long-term renal function in survivors of childhood Wilms tumor.
Pediatr Nephrol. 2017 Oct;32(10):1915-1925. doi: 10.1007/s00467-017-3673-9. Epub 2017 Apr 28.
6
Comparison of creatinine and cystatin C based eGFR in the estimation of glomerular filtration rate in Indigenous Australians: The eGFR Study.
Clin Biochem. 2017 Apr;50(6):301-308. doi: 10.1016/j.clinbiochem.2016.11.024. Epub 2016 Nov 25.
7
Impact of Serum Cystatin C-Based Glomerular Filtration Rate Estimates on Drug Dose Selection in Hospitalized Patients.
Pharmacotherapy. 2018 Oct;38(10):1068-1073. doi: 10.1002/phar.2175. Epub 2018 Sep 12.
9
Performance of the 2021 Race-Free CKD-EPI Creatinine- and Cystatin C-Based Estimated GFR Equations Among Kidney Transplant Recipients.
Am J Kidney Dis. 2022 Oct;80(4):462-472.e1. doi: 10.1053/j.ajkd.2022.03.014. Epub 2022 May 16.
10
Cystatin C and Creatinine Concentrations Are Uninformative Biomarkers of Sarcopenia: A Cross-Sectional NHANES Study.
J Ren Nutr. 2023 Jul;33(4):538-545. doi: 10.1053/j.jrn.2023.01.012. Epub 2023 Feb 15.

本文引用的文献

1
Systemic Biological Mechanisms of Neurocognitive Dysfunction in Long-Term Survivors of Childhood Hodgkin Lymphoma.
Clin Cancer Res. 2024 May 1;30(9):1822-1832. doi: 10.1158/1078-0432.CCR-23-3709.
2
Kidney Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.
Int J Radiat Oncol Biol Phys. 2024 Jun 1;119(2):560-574. doi: 10.1016/j.ijrobp.2023.02.040. Epub 2023 Jul 14.
3
Association Between Serum Cystatin C and Thyroid Diseases: A Systematic Review and Meta-Analysis.
Front Endocrinol (Lausanne). 2021 Nov 19;12:766516. doi: 10.3389/fendo.2021.766516. eCollection 2021.
4
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.
N Engl J Med. 2021 Nov 4;385(19):1737-1749. doi: 10.1056/NEJMoa2102953. Epub 2021 Sep 23.
5
Kidney Function after Treatment for Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study.
J Am Soc Nephrol. 2021 Apr;32(4):983-993. doi: 10.1681/ASN.2020060849. Epub 2021 Mar 2.
6
How unmeasured muscle mass affects estimated GFR and diagnostic inaccuracy.
EClinicalMedicine. 2020 Dec 1;29-30:100662. doi: 10.1016/j.eclinm.2020.100662. eCollection 2020 Dec.
7
Cohort Profile: The St. Jude Lifetime Cohort Study (SJLIFE) for paediatric cancer survivors.
Int J Epidemiol. 2021 Mar 3;50(1):39-49. doi: 10.1093/ije/dyaa203.
8
Kidney Outcomes and Hypertension in Survivors of Wilms Tumor: A Prospective Cohort Study.
J Pediatr. 2021 Mar;230:215-220.e1. doi: 10.1016/j.jpeds.2020.12.005. Epub 2020 Dec 5.
9
10
Cystatin C as a biomarker of chronic kidney disease: latest developments.
Expert Rev Mol Diagn. 2020 Oct;20(10):1019-1026. doi: 10.1080/14737159.2020.1768849. Epub 2020 May 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验